Product Detail
Palbociclib-d8
Palbociclib Stable Isotopes
Stock Status: In Stock
Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
Palbociclib
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for accurate information.
Palbociclib-d8 Product Information
Palbociclib-d8 is listed under Stable Isotopes. It is associated with Palbociclib and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-O-15447.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Palbociclib-d8
CAS No.
1628752-83-9
CAT No.
CS-O-15447
Molecular Formula
C₂₄H₂₁D₈N₇O₂
Molecular Weight
455.58
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
O=C1C(C(C)=O)=C(C)C2=CN=C(NC3=NC=C(N4C([2H])([2H])C([2H])([2H])NC([2H])([2H])C4([2H])[2H])C=C3)N=C2N1C5CCCC5
IUPAC Name
6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl)pyridin-2-
yl]amino]pyrido[2,3-d]pyrimidin-7-one
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.
Description
Overview
"Palbociclib-d8 is labelled Palbociclib, an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6."
Synonyms
Not available
Application Notes
"Palbociclib-d8 is labelled Palbociclib, an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6."
References
"Finn; R,; et al,: Breast Cancer Res,; 11; 5 (2009)"
